In ER+ breast cancer we observed that high MYC synergized with high RAS activation to provide a better prognostic stratification than either high MYC or high RAS alone (Figure 6A), and that this non-linear MYC-RAS interaction added prognostic value over the single-pathway models (Figure 6B). Here, MYC is linked to breast carcinoma.